Last edition
News about
Sanofi Canada announced that Health Canada has approved Sarclisa in combination with pomalidomide and dexamethasone for the treatment of adults with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor
Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals
GSK collaborates with Medicago to develop novel adjuvanted COVID-19 candidate vaccine
GSK and Medicago, a biopharmaceutical company, announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK's pandemic adjuvant system
Wipro 3D collaborates with SCTIMST launches emergency breathing assist system, AirBridge
Wipro 3D, a business of Wipro Infrastructure Engineering, in technical collaboration with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thrivuvananthapuram, has launched AirBridge, the Wipro Chitra Emergency Breathing Assist System (EBAS)
Thermo Fisher Scientific launches serology testing kit for infectious diseases
Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific MAS Omni Infectious Disease quality control sets for monitoring serological assays for analytes such as HIV 1&2, Hepatitis B & C virus, Syphilis and HTLV I/II
The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818
Medivir today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer
Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily
Thyrocare, India's leading diagnostic laboratory chain, has announced the availability of COVID Antibody Test to check your body's response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past
NPPA fixes retail prices of 14 formulations under DPCO 2013
NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order (DPCO)- 2013 relating to 76th Authority meeting dated June 22, 2020.
Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
AstraZeneca today announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy